Cite
Immunotherapy in hematological malignancies: recent advances and open questions.
MLA
Tawfik, Essam A., et al. “Immunotherapy in Hematological Malignancies: Recent Advances and Open Questions.” Immunotherapy (1750743X), vol. 13, no. 14, Oct. 2021, pp. 1215–29. EBSCOhost, https://doi.org/10.2217/imt-2021-0065.
APA
Tawfik, E. A., Aldrak, N. A., Albrahim, S. H., Alzahrani, D. A., Alfassam, H. A., Alkoblan, S. M., Almalik, A. M., Chen, K.-S., Abou-Khalil, R., Shah, K., & Zaidan, N. M. (2021). Immunotherapy in hematological malignancies: recent advances and open questions. Immunotherapy (1750743X), 13(14), 1215–1229. https://doi.org/10.2217/imt-2021-0065
Chicago
Tawfik, Essam A, Norah A Aldrak, Shahad H Albrahim, Dunia A Alzahrani, Haya A Alfassam, Samar M Alkoblan, Abdulaziz M Almalik, et al. 2021. “Immunotherapy in Hematological Malignancies: Recent Advances and Open Questions.” Immunotherapy (1750743X) 13 (14): 1215–29. doi:10.2217/imt-2021-0065.